Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 103

Sort by

Sort Order Select

Journal Articles

Beliefs, Opinions, and Impact of Emicizumab on Hemophilia Patients: A National U.S. Survey

Hanny Al-Samkari, MD, Stacy E. Croteau

Blood (2019) 134 (Supplement_1): 3395.

https://doi.org/10.1182/blood-2019-125364

Published: 2019

Journal Articles

Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)

Robert F. Sidonio, Jr., MD MSc, Bruce A. Schwartz, PhD

Blood (2019) 134 (Supplement_1): 4931.

https://doi.org/10.1182/blood-2019-128339

Published: 2019

Journal Articles

KIFC1 Mediates Centrosome Clustering Prior to Proplatelet Formation from Megakaryocytes

Adrian R. Wilkie, PhD, Leila J. Noetzli, PhD, Genevieve Couldwell, Anthony R. Sciaudone, Anjana Ray, PhD, Kellie R. Machlus, PhD, Joseph E. Italiano, Jr., BS, PhD

Blood (2019) 134 (Supplement_1): 721.

https://doi.org/10.1182/blood-2019-130803

Published: 2019

Journal Articles

Determining the Approximate Factor VIII Level Equivalency of Patients with Severe Hemophilia A on Emicizumab Using Global Hemostasis Assays

Hande Kizilocak, Elizabeth Marquez-Casas, BS, Jemily Malvar, MS, Roxana Carmona, MD, Guy Young, MD

Blood (2019) 134 (Supplement_1): 1134.

https://doi.org/10.1182/blood-2019-123820

Published: 2019

Journal Articles

Two Different Platelet Thresholds for Bleeding Prophylaxis in Children with Malignancies or Non-Malignant Disorders: The Bambino Gesù Children's Hospital Experience

Pierpaolo Berti, MD, Guglielmo Trua, MD, Francesco Lamura, MD, Laila Costantino, MD, Costantino Damico, MD, Alessandra Paoloni, MD, Maria Teresa Romano, MD, Katia Girardi, MD, Luisa Strocchio, MD, Elisabetta Cicchetti, Alessandra Bernardi, Valentina De Nava, Antonio Cappelli, Andrea Onetti Muda, MD PhD, Mauro Montanari, MD

Blood (2019) 134 (Supplement_1): 1173.

https://doi.org/10.1182/blood-2019-129132

Published: 2019

Journal Articles

VWF and FVIII Levels after Desmopressin Are Associated with the Bleeding Phenotype in Type 1 VWD

Ferdows Atiq, Lisette M. Schütte, MD, Agnes E.M. Looijen, Bsc, Johan Boender, MD, Moniek P.M. de Maat, PhD, Marieke J.H.A. Kruip, MD PhD, Frank W.G. Leebeek, MD PhD

Blood (2019) 134 (Supplement_1): 1116.

https://doi.org/10.1182/blood-2019-123634

Published: 2019

Journal Articles

Pharmacokinetics of Extended Half-Life Factor VIII Products By myPKFiT R Is Useful for Personalized Treatment in Children with Severe Hemophilia a

Risa Matsumura, Keita Tomioka, MD, Shiho Nishimura, MD, Yoko Mizoguchi, MD PhD, Hiroshi Kawaguchi, MD PhD, Masao Kobayashi, MD PhD

Blood (2019) 134 (Supplement_1): 1127.

https://doi.org/10.1182/blood-2019-128149

Published: 2019

Journal Articles

Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A

Alfonso Iorio, Monika Maas Enriquez, Heinz Delesen, Alexander Solms, Stacy E. Croteau, Erik Berntorp

Blood (2019) 134 (Supplement_1): 3637.

https://doi.org/10.1182/blood-2019-127046

Published: 2019

Journal Articles

Patient and Family Engagement during Treatment Change to Emicizumab at a Hemophilia Treatment Center

Susan U Lattimore, Madolyn T Hofstetter, BS

Blood (2019) 134 (Supplement_1): 5796.

https://doi.org/10.1182/blood-2019-131030

Published: 2019

Journal Articles

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Berardino Pollio, Maria Messina, Irene Ricca, Mauro Pagliarino, Ugo Ramenghi, MD, Antonio Coppola, Anna Castiglione, Giovannino Ciccone, Teresa Ceglie, Anna Mondino, Paolo Tavormina, Claudia Linari

Blood (2019) 134 (Supplement_1): 2400.

https://doi.org/10.1182/blood-2019-130023

Published: 2019

Journal Articles

A Neutralizing Monoclonal Antibody (PF-06741086) Against Tissue Factor Pathway Inhibitor in Combination with Activated Prothrombin Complex Concentrate Increases Hemostasis in Inhibitor Hemophilia Plasmas without Excessive Thrombin Generation

Swapnil Rakhe, MS, Sheryl Bowley, PhD, John E. Murphy, PhD, Debra D Pittman, MS

Blood (2018) 132 (Supplement 1): 3779.

https://doi.org/10.1182/blood-2018-99-119831

Published: 2018

Journal Articles

Opportunities for Improvement: The Lot of the Inhibitor Patient Is Not a Happy One

Frank V. McL. Booth, MA MSc BM BCh, Johnny Mahlangu, Howard Levy, PhD MBBChir

Blood (2018) 132 (Supplement 1): 5040.

https://doi.org/10.1182/blood-2018-99-111720

Published: 2018

Journal Articles

The Tissue Factor Pathway Inhibitor Antibody, PF-06741086, Increases Thrombin Generation in Rare Bleeding Disorder and Von Willebrand Factor Deficient Plasmas

Swapnil Rakhe, MS, Sunita R. Patel-Hett, PhD, Sheryl Bowley, PhD, John E. Murphy, PhD, Debra D Pittman, MS

Blood (2018) 132 (Supplement 1): 2462.

https://doi.org/10.1182/blood-2018-99-119674

Published: 2018

Journal Articles

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

Blood (2018) 132 (Supplement 1): 487.

https://doi.org/10.1182/blood-2018-99-115495

Published: 2018

Journal Articles

Impact of Interleukin-6 and Interleukin-10 Gene Polymorphisms on Inhibitor Development in Patients with Moderate and Severe Hemophilia a

Hoda Hassab, MD, Marwa Hanafi, Ahmed Abdelmaksoud, Shimaa ElSayed

Blood (2018) 132 (Supplement 1): 5026.

https://doi.org/10.1182/blood-2018-99-117479

Published: 2018

Journal Articles

Straightforward Transition to Bay 81-8973 Prophylaxis in Patients with Hemophilia A: Prospective Real-World Data from the Taurus Non-Interventional Study Show That Number of Infusions per Week Is Maintained or Reduced

Michael Wang, Beng Fuh, MD, Philip Maes, MD, Maria Eva Mingot-Castellano, PhD MD, Rubén Berrueco, MD, Phu-Quoc Le, MD PhD, Stephan Rauchensteiner, Cristina Santoro, MD PhD

Blood (2018) 132 (Supplement 1): 5045.

https://doi.org/10.1182/blood-2018-99-116622

Published: 2018

Journal Articles

Platelets and vascular integrity: how platelets prevent bleeding in inflammation

Benoit Ho-Tin-Noé, Yacine Boulaftali, Eric Camerer

Blood (2018) 131 (3): 277–288.

https://doi.org/10.1182/blood-2017-06-742676

Published: 2018

Journal Articles

Individualized Prophylaxis with BAY 81-8973: Clinical Experience in an Italian Patient with Severe Hemophilia A

Rita Carlotta Santoro, Piergiorgio Iannaccaro

Blood (2017) 130 (Supplement 1): 4891.

https://doi.org/10.1182/blood.V130.Suppl_1.4891.4891

Published: 2017

Journal Articles

Switching Kogenate FS® to Kovaltry® for the Treatment of Severe Haemophilia A Patients: A Successful Single Center Experience

Teresa Álvarez-Roman, Paula Acutilde accent is not displayed approve the letter na, Nora Butta, Mónica Martín, María Isabel Rivas Pollmar, Ihosvany Fernandez-Bello, Miguel A. Canales, Victor Jimenez-Yuste

Blood (2017) 130 (Supplement 1): 4882.

https://doi.org/10.1182/blood.V130.Suppl_1.4882.4882

Published: 2017

Journal Articles

Rationale for and Design of a Tolerability and Safety Study of FEIBA Reconstituted in Regular or 50% Reduced Volume and Faster Infusion Rates in Patients with Hemophilia A or B with Inhibitors

Talaha Mubarak Ali, Naghmana Bajwa

Blood (2017) 130 (Supplement 1): 4886.

https://doi.org/10.1182/blood.V130.Suppl_1.4886.4886

Published: 2017

NARROW

Beliefs, Opinions, and Impact of Emicizumab on Hemophilia Patients: A National U.S. Survey

Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)

KIFC1 Mediates Centrosome Clustering Prior to Proplatelet Formation from Megakaryocytes

Determining the Approximate Factor VIII Level Equivalency of Patients with Severe Hemophilia A on Emicizumab Using Global Hemostasis Assays

Two Different Platelet Thresholds for Bleeding Prophylaxis in Children with Malignancies or Non-Malignant Disorders: The Bambino Gesù Children's Hospital Experience

VWF and FVIII Levels after Desmopressin Are Associated with the Bleeding Phenotype in Type 1 VWD

Pharmacokinetics of Extended Half-Life Factor VIII Products By myPKFiT R Is Useful for Personalized Treatment in Children with Severe Hemophilia a

Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A

Patient and Family Engagement during Treatment Change to Emicizumab at a Hemophilia Treatment Center

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

A Neutralizing Monoclonal Antibody (PF-06741086) Against Tissue Factor Pathway Inhibitor in Combination with Activated Prothrombin Complex Concentrate Increases Hemostasis in Inhibitor Hemophilia Plasmas without Excessive Thrombin Generation

Opportunities for Improvement: The Lot of the Inhibitor Patient Is Not a Happy One

The Tissue Factor Pathway Inhibitor Antibody, PF-06741086, Increases Thrombin Generation in Rare Bleeding Disorder and Von Willebrand Factor Deficient Plasmas

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

Impact of Interleukin-6 and Interleukin-10 Gene Polymorphisms on Inhibitor Development in Patients with Moderate and Severe Hemophilia a

Straightforward Transition to Bay 81-8973 Prophylaxis in Patients with Hemophilia A: Prospective Real-World Data from the Taurus Non-Interventional Study Show That Number of Infusions per Week Is Maintained or Reduced

Platelets and vascular integrity: how platelets prevent bleeding in inflammation

Individualized Prophylaxis with BAY 81-8973: Clinical Experience in an Italian Patient with Severe Hemophilia A

Switching Kogenate FS® to Kovaltry® for the Treatment of Severe Haemophilia A Patients: A Successful Single Center Experience

Rationale for and Design of a Tolerability and Safety Study of FEIBA Reconstituted in Regular or 50% Reduced Volume and Faster Infusion Rates in Patients with Hemophilia A or B with Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only